Skip to main content
Finemedix Co., Ltd. logo

Finemedix Co., Ltd. — Investor Relations & Filings

Ticker · 387570 ISIN · KR7387570005 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-08-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 387570

About Finemedix Co., Ltd.

https://finemedix.com/en/

Finemedix Co., Ltd. is a medical device company that develops and manufactures surgical equipment, specializing in instruments for endoscopic procedures. The company's product portfolio supports diagnostic and therapeutic applications, including Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) and Fine Needle Biopsy (EUS-FNB) devices, hemostatic clips for bleeding control, and tools for Endoscopic Submucosal Dissection (ESD) and polypectomy. Finemedix operates on a prosumer model, directly involving medical personnel in the product development process to create devices tailored to clinical needs.

Recent filings

Filing Released Lang Actions
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 파인메딕스' covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's leadership, specifically the resignation of one of the co-CEOs. It details the 'before' and 'after' status of the representative directors, the reason for the change, and the effective date. This falls directly under the category of Board/Management Information (MANG).
2025-06-30 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 파인메딕스' (Finemedix Co., Ltd.) covering the period from 2025-01-01 to 2025-03-31. It contains detailed financial information, business operations, and management reports, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Jeon Seong-woo) and special related parties in the company 'FineMedix'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on 2025-03-26, including financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors for the company 'FineMedix'. This type of disclosure specifically concerns changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2025-03-26 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.